...
首页> 外文期刊>Journal of cellular and molecular medicine. >Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer
【24h】

Exosomal miRNAs as circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer

机译:外泌体miRNA作为循环生物标志物,用于预测阶段II / III胃癌手术后血液源转移的发育

获取原文
           

摘要

Exosomes secreted by living cancer cells can regulate metastasis. Exosomal miRNAs can reflect pathological conditions of the original cancer cells. Therefore, we aim to identify exosomal miRNAs as circulating biomarkers for haematogenous metastasis of gastric cancer. Pre‐treatment serum samples of eighty‐nine patients with stage II/III gastric cancer were collected. Thirty‐four of them developed haematogenous metastasis after surgery and the other fifty‐five did not. Extraction of exosomes was validated by western blot, transmission electron microscopy and nanoparticle tracking analysis. MiRNA qPCR array was performed in three matched pairs of samples. Internal control was selected from PCR array and validated in the remaining samples. Expressions of exosomal miRNAs were evaluated in the remaining samples by RT‐qPCR, as well as in gastric cancer tissue samples and cell culture medium. Expression levels of exosomal miRNAs were analysed with clinical characteristics. The results indicated thirteen up‐regulated and six down‐regulated miRNAs were found after normalization. MiR‐379‐5p and miR‐410‐3p were significantly up‐regulated in metastatic patients ( P ?.01). Higher expression of exosomal miR‐379‐5p or miR‐410‐3p showed shorter progression‐free survival of the patients ( P ?.05). It was also found that miR‐379‐5p and miR‐410‐3p were down‐regulated in gastric cancer tissue samples, while they were significantly up‐regulated in gastric cancer cell culture medium compared with cancer cells. In conclusion, exosomal miRNAs are promising circulating biomarkers for prediction of development of haematogenous metastasis after surgery for stage II/III gastric cancer.
机译:通过生物癌细胞分泌的外来体可以调节转移。外泌体miRNA可以反映原始癌细胞的病理条件。因此,我们的目的是将外泌体miRNA鉴定为循环生物标志物,用于胃癌的血液源性转移。收集八十九届患者患者的预治疗血清样本。他们在手术后三十四个发育出血转移,另一个五十五个没有。通过蛋白质印迹,透射电子显微镜和纳米粒子跟踪分析验证外泌体的提取。 miRNA QPCR阵列是在三个匹配的样品上进行的。从PCR阵列中选择内部对照并在其余样本中验证。通过RT-QPCR以及胃癌组织样品和细胞培养基在剩余的样品中评估外泌体miRNA的表达。通过临床特征分析外泌体miRNA的表达水平。结果表明,标准化后发现了13起上调和六个下调的miRNA。 MiR-379-5P和MIR-410-3P在转移性患者中显着上调(P <-OX.01)。 Exosomal miR-379-5p或miR-410-3p的更高表达显示出患者的无进展生存率较短(p <β.05)。还发现MiR-379-5P和MIR-410-3P在胃癌组织样品中下调,而与癌细胞相比,它们在胃癌细胞培养基中显着上调。总之,外泌体MiRNA是有前途的循环生物标志物,用于预测阶段II / III胃癌患者血液源转移的发育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号